Images
Participants
Contact
EFE Agency has echoed the research performed by Carles Pons, Research Associate in Patrick Aloy's lab (Structural Bioinformatics and Network Biology) at IRB Barcelona, recently published in Science. The study presents the first comprehensive set of suppressive mutations in a cell. Its findings could help “explain how suppressive mutations combine with disease-causing mutations to soften the blow of a disease, or even completely protect against it”.
Link to EFE Agency
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
